Bioiberica

Bioiberica is a 50-year-old, privately-held Spanish company that has established itself as a global leader in heparin production and a diversified provider of bioactive ingredients. Its business model leverages a unique circular economy approach, transforming biological co-products into high-value molecules for human health, animal nutrition, and crop science. With over 100 products, a portfolio of 50+ patents, and exports to 80+ countries from nine international production sites, Bioiberica combines deep scientific expertise with a vertically integrated manufacturing footprint. The company is revenue-generating and commercially focused, driving growth through innovation in biologics and strategic partnerships across multiple life science sectors.

Expertise in extraction, purification, and application of complex biomolecules (glycosaminoglycans, collagens) from biological sources, leveraging a circular economy model and advanced bioprocessing.

Bioiberica competes as a leading supplier in niche biomolecule markets. In heparin, it faces competition from other API manufacturers like Shenzhen Hepalink and Pfizer. In nutraceutical and animal health ingredients, it competes with diversified firms like DSM-Firmenich, Kerry Group, and specialized ingredient suppliers.